General guidance on exploratory and confirmatory subgroup analysis in late-stage clinical trials

Introduction to Meta‐Analysis

Borenstein, M., Hedges, L. V., Higgins, J. P. T., & Rothstein, H. R. (2009) · doi:10.1002/9780470743386 · Cited by 14,225 · see citing works

Introduction to Meta‐Analysis

Borenstein, M., Hedges, L. V., Higgins, J. P. T., & Rothstein, H. R. (2021) · doi:10.1002/9781119558378 · Cited by 9,799 · see citing works

Unbiased Recursive Partitioning: A Conditional Inference Framework

Hothorn, T., Hornik, K., & Zeileis, A. (2006) · Journal of Computational and Graphical Statistics · doi:10.1198/106186006x133933 · Cited by 4,021 · see citing works

Stability Selection

Meinshausen, N., & Bühlmann, P. (2010) · Journal of the Royal Statistical Society Series B (Statistical Methodology) · doi:10.1111/j.1467-9868.2010.00740.x · Cited by 2,317 · see citing works

Regression Using Fractional Polynomials of Continuous Covariates: Parsimonious Parametric Modelling

Royston, P. J., & Altman, D. G. (1994) · Journal of the Royal Statistical Society Series C (Applied Statistics) · doi:10.2307/2986270 · Cited by 1,797 · see citing works

Subgroup analysis and other (mis)uses of baseline data in clinical trials

Assmann, S. F., Pocock, S. J., Enos, L. E., & Kasten, L. E. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02039-0 · Cited by 1,167 · see citing works

Analysis and interpretation of treatment effects in subgroups of patients in randomized clinical trials

Yusuf, S. (1991) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1991.03470010097038 · Cited by 1,014 · see citing works

SPLIT SELECTION METHODS FOR CLASSIFICATION TREES

Loh, W., & Shih, Y. (1997) · Cited by 933 · see citing works

Estimating Individualized Treatment Rules Using Outcome Weighted Learning

Zhao, Y., Zeng, D., Rush, A. J., & Kosorok, M. R. (2012) · Journal of the American Statistical Association · doi:10.1080/01621459.2012.695674 · Cited by 746 · see citing works

Bump hunting in high-dimensional data

Friedman, J. H., & Fisher, N. I. (1999) · Statistics and Computing · doi:10.1023/a:1008894516817 · Cited by 605 · see citing works

Subgroup identification from randomized clinical trial data

Foster, J. C., Taylor, J. M. G., & Ruberg, S. J. (2011) · Statistics in Medicine · doi:10.1002/sim.4322 · Cited by 541 · see citing works

Testing for baseline balance in clinical trials

Senn, S. (1994) · Statistics in Medicine · doi:10.1002/sim.4780131703 · Cited by 503 · see citing works

Estimating treatment effect heterogeneity in randomized program evaluation

Imai, K., & Ratkovic, M. (2013) · The Annals of Applied Statistics · doi:10.1214/12-aoas593 · Cited by 487 · see citing works

A Robust Method for Estimating Optimal Treatment Regimes

Zhang, B., Tsiatis, A. A., Laber, E. B., & Davidian, M. (2012) · Biometrics · doi:10.1111/j.1541-0420.2012.01763.x · Cited by 422 · see citing works

A Simple Method for Estimating Interactions Between a Treatment and a Large Number of Covariates

Tian, L., Alizadeh, A. A., Gentles, A. J., & Tibshirani, R. J. (2014) · Journal of the American Statistical Association · doi:10.1080/01621459.2014.951443 · Cited by 378 · see citing works

The Evaluation of Surrogate Endpoints

Loughin, T. M., Buckl, S. T., Anderson, D. R., Burnham, K. P., Laake, J. L., Borchers, D. L., Thomas, L., Alpizar-jara, R., Fortin, M. J., Shanbhag, D. N., et al. (2005) · Statistics in the health sciences · doi:10.1007/b138566 · Cited by 312 · see citing works

Tutorial in biostatistics: data‐driven subgroup identification and analysis in clinical trials

Lipkovich, I., Dmitrienko, A., & B., R. (2017) · Statistics in Medicine · doi:10.1002/sim.7064 · Cited by 291 · see citing works

Subgroup identification based on differential effect search—A recursive partitioning method for establishing response to treatment in patient subpopulations

Lipkovich, I. A., Dmitrienko, A. A., Denne, J. S., & Enas, G. G. (2011) · Statistics in Medicine · doi:10.1002/sim.4289 · Cited by 282 · see citing works

A new approach to modelling interactions between treatment and continuous covariates in clinical trials by using fractional polynomials

Royston, P. J., & Sauerbrei, W. (2004) · Statistics in Medicine · doi:10.1002/sim.1815 · Cited by 281 · see citing works

Multiple Testing Problems in Pharmaceutical Statistics

(2009) · Chapman & Hall/CRC eBooks · doi:10.1201/9781584889854 · Cited by 274 · see citing works

Generalized Maximally Selected Statistics

Hothorn, T., & Zeileis, A. (2008) · Biometrics · doi:10.1111/j.1541-0420.2008.00995.x · Cited by 259 · see citing works

An adaptive seamless phase II/III design for oncology trials with subpopulation selection using correlated survival endpoints†

Jenkins, M. A., Stone, A. M., & Jennison, C. (2010) · Pharmaceutical Statistics · doi:10.1002/pst.472 · Cited by 214 · see citing works

Confirmatory adaptive designs with Bayesian decision tools for a targeted therapy in oncology

Brannath, W., Zuber, E., Branson, M., Bretz, F., Gallo, P. P., Posch, M., & Racine-Poon, A. (2009) · Statistics in Medicine · doi:10.1002/sim.3559 · Cited by 200 · see citing works

Journal of Biopharmaceutical Statistics

Peace, K. E., & Chow, S. (2005) · Encyclopedia of Biostatistics · doi:10.1002/0470011815.b2a17077 · Cited by 196 · see citing works

A regression tree approach to identifying subgroups with differential treatment effects

Loh, W., He, X., & Man, M. Z. (2015) · Statistics in Medicine · doi:10.1002/sim.6454 · Cited by 187 · see citing works

Patterns of treatment effects in subsets of patients in clinical trials

Bonetti, M. (2004) · Biostatistics · doi:10.1093/biostatistics/kxh002 · Cited by 160 · see citing works

Traditional multiplicity adjustment methods in clinical trials

Dmitrienko, A. A., & D’Agostino, R. B. (2013) · Statistics in Medicine · doi:10.1002/sim.5990 · Cited by 153 · see citing works

Patterns of treatment effects in subsets of patients in clinical trials

Bonetti, M. (2004) · Biostatistics · doi:10.1093/biostatistics/5.3.465 · Cited by 152 · see citing works

Points to Consider on Multiplicity Issues in Clinical Trials

Watanabe, H. A., & Takahashi, K. (2006) · Japanese Journal of Biometrics · doi:10.5691/jjb.27.s73 · Cited by 151 · see citing works

Methods for identification and confirmation of targeted subgroups in clinical trials: A systematic review

Ondra, T., Dmitrienko, A. A., Friede, T., Graf, A. C., Miller, F., Stallard, N., & Posch, M. (2015) · Journal of Biopharmaceutical Statistics · doi:10.1080/10543406.2015.1092034 · Cited by 122 · see citing works

Interaction Trees with Censored Survival Data

Su, X., Zhou, T., Yan, X., Fan, J., & Song, Y. (2008) · The International Journal of Biostatistics · doi:10.2202/1557-4679.1071 · Cited by 108 · see citing works

A Bayesian Approach to Subgroup Identification

Berger, J. O., Wang, X., & Shen, L. (2014) · Journal of Biopharmaceutical Statistics · doi:10.1080/10543406.2013.856026 · Cited by 104 · see citing works

Bayesian models for subgroup analysis in clinical trials

Jones, H. E., Ohlssen, D. I., Neuenschwander, B. E., Racine, A., & Branson, M. (2011) · Clinical Trials · doi:10.1177/1740774510396933 · Cited by 103 · see citing works

A conditional error function approach for subgroup selection in adaptive clinical trials

Friede, T., Parsons, N., & Stallard, N. (2012) · Statistics in Medicine · doi:10.1002/sim.5541 · Cited by 97 · see citing works

Key multiplicity issues in clinical drug development

Dmitrienko, A. A., D’Agostino, R. B., & Huque, M. F. (2012) · Statistics in Medicine · doi:10.1002/sim.5642 · Cited by 96 · see citing works

Randomized Phase II Trial Designs With Biomarkers

Freidlin, B., McShane, L. M., Polley, M. C., & Korn, E. L. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2012.43.3946 · Cited by 89 · see citing works

A flexible strategy for testing subgroups and overall population

Alosh, M., & Huque, M. F. (2008) · Statistics in Medicine · doi:10.1002/sim.3461 · Cited by 76 · see citing works

Adaptive Designs for Confirmatory Clinical Trials with Subgroup Selection

Stallard, N., Hamborg, T., Parsons, N., & Friede, T. (2014) · Journal of Biopharmaceutical Statistics · doi:10.1080/10543406.2013.857238 · Cited by 69 · see citing works

Subgroup Analyses in Randomized Clinical Trials: Statistical and Regulatory Issues

Grouin, J., Coste, M., & Lewis, J. A. (2005) · Journal of Biopharmaceutical Statistics · doi:10.1081/bip-200067988 · Cited by 61 · see citing works

Personalized Medicine: Four Perspectives of Tailored Medicine

Ruberg, S. J., & Shen, L. (2015) · Statistics in Biopharmaceutical Research · doi:10.1080/19466315.2015.1059354 · Cited by 61 · see citing works

A small sample study of the STEPP approach to assessing treatment–covariate interactions in survival data

Bonetti, M., Zahrieh, D., Cole, B. F., & Gelber, R. D. (2009) · Statistics in Medicine · doi:10.1002/sim.3524 · Cited by 45 · see citing works

Variable Selection for Qualitative Interactions in Personalized Medicine While Controlling the Family-Wise Error Rate

Gunter, L., Zhu, J., & Murphy, S. A. (2011) · Journal of Biopharmaceutical Statistics · doi:10.1080/10543406.2011.608052 · Cited by 41 · see citing works

A Statistical Framework for Decision Making in Confirmatory Multipopulation Tailoring Clinical Trials

Millen, B. A., Dmitrienko, A. A., Ruberg, S. J., & Shen, L. (2012) · Drug Information Journal · doi:10.1177/0092861512454116 · Cited by 41 · see citing works

Interaction of treatment with a continuous variable: simulation study of significance level for several methods of analysis

Royston, P. J., & Sauerbrei, W. (2013) · Statistics in Medicine · doi:10.1002/sim.5813 · Cited by 40 · see citing works

Multiplicity considerations in subgroup analysis

Dmitrienko, A. A., Millen, B. A., & Lipkovich, I. A. (2017) · Statistics in Medicine · doi:10.1002/sim.7416 · Cited by 39 · see citing works

Design and Analysis Considerations in Clinical Trials With a Sensitive Subpopulation

Zhao, Y. D., Dmitrienko, A. A., & Tamura, R. (2010) · Statistics in Biopharmaceutical Research · doi:10.1198/sbr.2010.08039 · Cited by 36 · see citing works

Retrospective validation of genomic biomarkers – what are the questions, challenges and strategies for developing useful relationships to clinical outcomes – workshop summary

Wang, S.-J., Cohen, N., Katz, D. A., Ruaño, G., Shaw, P. M., & Spear, B. (2006) · The Pharmacogenomics Journal · doi:10.1038/sj.tpj.6500363 · Cited by 32 · see citing works

Eliciting and using expert opinions about influence of patient characteristics on treatment effects: a Bayesian analysis of the CHARM trials

White, I. R., Pocock, S., & Wang, D. (2005) · Statistics in Medicine · doi:10.1002/sim.2420 · Cited by 31 · see citing works

An Overview of Statistical Planning to Address Subgroups in Confirmatory Clinical Trials

Koch, G. G., & Schwartz, T. A. (2014) · Journal of Biopharmaceutical Statistics · doi:10.1080/10543406.2013.856021 · Cited by 29 · see citing works

A Regulatory Perspective on Essential Considerations in Design and Analysis of Subgroups When Correctly Classified

Wang, S.-J., & Hung, H. (2014) · Journal of Biopharmaceutical Statistics · doi:10.1080/10543406.2013.856022 · Cited by 26 · see citing works

Bayesian Assessment of the Influence and Interaction Conditions in Multipopulation Tailoring Clinical Trials

Millen, B. A., Dmitrienko, A. A., & Song, G. (2014) · Journal of Biopharmaceutical Statistics · doi:10.1080/10543406.2013.856025 · Cited by 24 · see citing works

An Overview of Statistical and Regulatory Issues in the Planning, Analysis, and Interpretation of Subgroup Analyses in Confirmatory Clinical Trials

Hemmings, R. (2014) · Journal of Biopharmaceutical Statistics · doi:10.1080/10543406.2013.856747 · Cited by 22 · see citing works

Reliably Basing Conclusions on Subgroups of Randomized Clinical Trials

Koch, A., & Framke, T. (2014) · Journal of Biopharmaceutical Statistics · doi:10.1080/10543406.2013.856020 · Cited by 22 · see citing works

Interpretation of Subgroup Analyses in Clinical Trials

Fleming, T. R. (1995) · Drug Information Journal · doi:10.1177/00928615950290s114 · Cited by 19 · see citing works

Multiplicity considerations for subgroup analysis subject to consistency constraint

Alosh, M., & Huque, M. F. (2013) · Biometrical Journal · doi:10.1002/bimj.201200065 · Cited by 18 · see citing works

Statistical Perspectives on Subgroup Analysis: Testing for Heterogeneity and Evaluating Error Rate for the Complementary Subgroup

Alosh, M., Huque, M. F., & Koch, G. G. (2014) · Journal of Biopharmaceutical Statistics · doi:10.1080/10543406.2014.971169 · Cited by 15 · see citing works

Multiplicity Problems in Clinical Trials

Huque, M. F., & Röhmel, J. (2009) · Chapman & Hall/CRC biostatistics series · doi:10.1201/9781584889854-c1 · Cited by 10 · see citing works

Statistical Issues in Drug Development (Second edition)

Senn, S. J. (2007) · Cited by 9 · see citing works

Biomarker Evaluation and Subgroup Identification in a Pneumonia Development Program Using SIDES

Dmitrienko, A. A., Lipkovich, I. A., Hopkins, A., Li, Y., & Wang, W. (2015) · ICSA book series in statistics · doi:10.1007/978-3-319-12694-4_26 · Cited by 7 · see citing works

Japanese Guideline on Global Clinical Trials: Statistical Implications and Alternative Criteria for Assessing Consistency

Carroll, K. J., & Maulf, F. L. (2011) · Drug Information Journal · doi:10.1177/009286151104500616 · Cited by 6 · see citing works

Multipopulation Tailoring Clinical Trials: Design, Analysis, and Inference Considerations

Millen, B. A., Dmitrienko, A. A., Mandrekar, S. J., et al. (2014) · Therapeutic Innovation & Regulatory Science · doi:10.1177/2168479013519630 · Cited by 6 · see citing works

Tutorial in biostatistics: data‐driven subgroup identification and analysis in clinical trials

Lipkovich, I., Dmitrienko, A., & B., R. (2017) · Statistics in Medicine · doi:10.1002/sim.7064 · Cited by 291 · see citing works

Impact of Icosapent Ethyl on Cardiovascular Risk Reduction in Patients With Heart Failure in REDUCE‐IT

Selvaraj, S., Bhatt, D. L., Steg, P. G., Miller, M., Brinton, E. A., Jacobson, T. A., Juliano, R. A., Jiao, L., Tardif, J., Ballantyne, C. M., et al. (2022) · Journal of the American Heart Association · doi:10.1161/jaha.121.024999 · Cited by 31 · see citing works

No improvement in the reporting of clinical trial subgroup effects in high-impact general medical journals

Gabler, N. B., Duan, N., Raneses, E., Suttner, L. H., Ciarametaro, M., Cooney, E. L., Dubois, R. W., Halpern, S. D., & Kravitz, R. L. (2016) · Trials · doi:10.1186/s13063-016-1447-5 · Cited by 39 · see citing works

Some Results on Cross Viewpoint Consistency Checking

Bowman, H., Derrick, J., & Steen, M. W. A. (1995) · Springer eBooks · doi:10.1007/978-0-387-34882-7_31 · Cited by 13 · see citing works

Prespecification of subgroup analyses and examination of treatment-subgroup interactions in cancer individual participant data meta-analyses are suboptimal

Gao, Y., Liu, M., Shi, S., Niu, M., Jiang, L., Zhang, J., Song, F., & Tian, J. (2021) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2021.06.019 · Cited by 6 · see citing works

On Quantitative Metrics for the Consistency and Availability in Distributed Databases

Zlygostev, A. I., & Pishik, B. N. (2022) · Vestnik NSU Series Information Technologies · doi:10.25205/1818-7900-2022-20-2-18-26

Cumulative subgroup analysis to reduce waste in clinical research for individualised medicine

Song, F., & Bachmann, M. O. (2016) · BMC Medicine · doi:10.1186/s12916-016-0744-x · Cited by 18 · see citing works